Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis
- PMID: 26491362
- PMCID: PMC4608596
- DOI: 10.2147/OTT.S92259
Genetic polymorphisms of CYP1A1 and risk of leukemia: a meta-analysis
Abstract
The associations between CYP1A1 polymorphisms and risk of leukemia have been studied extensively, but the results have been inconsistent. Therefore, in this study, we performed a meta-analysis to clarify associations of three CYP1A1 polymorphisms (T3801C, A2455G, and C4887A) with the risks of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML). Medline, EMBASE, and China National Knowledge Infrastructure databases were searched to collect relevant studies published up to April 20, 2015. The extracted data were analyzed statistically, and pooled odds ratios with 95% confidence intervals were calculated to quantify the associations. Overall, 26 publications were included. Finally, T3801C was associated with an increased risk of AML in Asians under the dominant model. For A2455G, the risk of ALL was increased among Caucasians in the recessive model and the allele-contrast model; A2455G was also associated with an increased risk of CML among Caucasians under the recessive model, dominant model, and allele-contrast model. For C4887A, few of the included studies produced data. In conclusion, the results suggest that Asians carrying the T3801C C allele might have an increased risk of AML and that Caucasians with the A2455G GG genotype might have an increased risk of ALL. Further investigations are needed to confirm these associations.
Keywords: ALL; AML; CML; CYP1A1; polymorphism.
Figures











Similar articles
-
Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis.Blood Res. 2024 Mar 4;59(1):9. doi: 10.1007/s44313-024-00007-9. Blood Res. 2024. PMID: 38485870 Free PMC article.
-
Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.PLoS One. 2021 Apr 28;16(4):e0249632. doi: 10.1371/journal.pone.0249632. eCollection 2021. PLoS One. 2021. PMID: 33909612 Free PMC article.
-
Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis.Mol Biol Rep. 2013 Oct;40(10):6035-42. doi: 10.1007/s11033-013-2713-1. Epub 2013 Sep 25. Mol Biol Rep. 2013. PMID: 24065535
-
Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis.J Hum Genet. 2007;52(5):423. doi: 10.1007/s10038-007-0131-8. Epub 2007 Apr 11. J Hum Genet. 2007. PMID: 17427032
-
Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.Breast Cancer Res Treat. 2010 Jul;122(2):503-7. doi: 10.1007/s10549-009-0717-2. Epub 2010 Jan 6. Breast Cancer Res Treat. 2010. PMID: 20052535 Review.
Cited by
-
Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta-analysis.Blood Res. 2024 Mar 4;59(1):9. doi: 10.1007/s44313-024-00007-9. Blood Res. 2024. PMID: 38485870 Free PMC article.
-
The association of the CYP1A1 Ile462Val polymorphism with head and neck cancer risk: evidence based on a cumulative meta-analysis.Onco Targets Ther. 2016 May 17;9:2927-34. doi: 10.2147/OTT.S106264. eCollection 2016. Onco Targets Ther. 2016. PMID: 27274286 Free PMC article.
-
New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases.Acta Pharm Sin B. 2020 Jan;10(1):91-104. doi: 10.1016/j.apsb.2019.11.016. Epub 2019 Dec 2. Acta Pharm Sin B. 2020. PMID: 31998606 Free PMC article. Review.
-
Association of B-Lineage Lymphoblastic Leukaemia Gene Polymorphisms with Poor Prognostic Features.Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4339-4349. doi: 10.31557/APJCP.2024.25.12.4339. Asian Pac J Cancer Prev. 2024. PMID: 39733427 Free PMC article.
-
Correlation of Genetic Variants and the Incidence, Prevalence and Mortality Rates of Acute Lymphoblastic Leukemia.J Pers Med. 2022 Feb 28;12(3):370. doi: 10.3390/jpm12030370. J Pers Med. 2022. PMID: 35330370 Free PMC article.
References
-
- Huang Y, Xie D, Tang N, et al. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls. Tumour Biol. 2014;35(1):799–808. - PubMed
-
- Infante-Rivard C, Labuda D, Krajinovic M, Sinnett D. Risk of childhood leukemia associated with exposure to pesticides and with gene polymorphisms. Epidemiology. 1999;10(5):481–487. - PubMed
-
- Guengerich FP, Shimada T. Activation of procarcinogens by human cytochrome P450 enzymes. Mutat Res. 1998;400(1–2):201–213. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous